Projects per year
Personal profile
Career
| 2021 - 2024 | Director Otto Loewi Research Center |
| 2014 - 2023 | Board Member of the Austrian Science Fund FWF |
| 2012 - 2021 | Speaker of the FWF-Doktoratskolleg DK-MOLIN |
| 2009 - | Professor and Chair of Pharmacology |
| 2006 - 2024 | Speaker of the PhD Program MOLMED |
| 2000 - | Appointed Reader in Pharmacology |
| 1998 - 1999 | Post-doctoral fellow at the Imperial College Medical School, Leukocyte Biology Section, London, UK |
| 1995 - 2003 | Registrar in Pharmacology at the Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria |
| 1992 - 1995 | Research fellow at the Department of Internal Medicine, Medical University of Graz, Austria |
| 1984 - 1991 | Study of Medicine at the Medical School of the Karl Franzens University Graz (now Medical University of Graz) |
Further information
Branches of science
- 301 Medical-Theoretical Sciences, Pharmacy
- 302 Clinical Medicine
Fingerprint
Dive into the research topics where Akos Heinemann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 13 Finished
-
RESPIMMUN: RESPIMMUN
Heinemann, A. (Principal investigator)
1/10/21 → 30/11/25
Project: Research funding
-
DP-iDP: Inflammatory Disorders in Pregnancy
Heinemann, A. (Principal investigator)
1/10/18 → 30/09/22
Project: Research funding
-
BioTechMed Leuchtturmprojekt Lipid Signaling
Heinemann, A. (Principal investigator)
1/01/17 → 31/12/17
Project: Research funding
-
DK-MOLIN: DK "Molecular Fundamentals of Inflammation" (2. funding period)
Heinemann, A. (Principal investigator)
1/10/16 → 2/10/20
Project: Research funding
-
DK-MOLIN: DK "Molecular Fundamentals of Inflammation" - Koordination (2. funding periode)
Heinemann, A. (Principal investigator)
1/03/16 → 30/06/21
Project: Research funding
-
Brepocitinib, a selective TYK2/JAK1 inhibitor, mitigates neutrophilic inflammation and glucocorticoid receptor-β expression in COPD.
Nayak, B. B. (First author), Bärnthaler, T., Rajesh, R., Teppan, J., Gogg, T., Douschan, P., Kneidinger, N., van der Does, A., Hiemstra, P., Heinemann, A. & Böhm, E. (Last author), 1 Feb 2026, In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 330, 2, p. L178-L197 20 p.Research output: Contribution to journal › Research article
1 Citation (Web of Science) -
Diethyl Succinate Exerts Anti-fibrotic Effects in Preclinical Models of Pulmonary Fibrosis
Rajesh, R., Schweighofer, H., Mooslechner, A., Pahernik, S., Lanz, I., Kwapiszewska, G., Gurczynski, S. J., Moore, B. B., Heinemann, A. & Baernthaler, T., May 2026, In: American Journal of Respiratory and Critical Care Medicine. 212, 2 p., aamag1622588.Research output: Contribution to journal › Conference abstract
-
Age-related alterations of the molecular circadian clock in human leukocytes in health and disease.
Gogg, T., Teppan, J., Hampuch, A., Pahernik, S., Bärnthaler, T., Heinemann, A. & Böhm, E., 2025, In: Intrinsic Activity.Research output: Contribution to journal › Conference abstract
-
Celebration of the Sesquicentennial of Otto Loewi (1873-1961): The Nobel Prize Laureate Physiologist and Pharmacologist.
Pereira Dutra, P., Gomes, M., Mendlowicz, M., Heinemann, A. & Nardi, A., Jan 2025, In: Molecular Psychiatry. 30, 1, p. 360-362 3 p.Research output: Contribution to journal › Communication
-
Emergency Pharmacological Relevance of the EMA-Warning on Metamizole
Heinemann, A. (First author), Ittner, K., Koppenberg, J., Mansberger, P., Neubert, A., Prückner, S. & Walter, U., Jun 2025, In: Notarzt. 41, 03, 4 p.Research output: Contribution to journal › Communication
-
The role of JAK/STAT signaling in neutrophilic airway inflammation
Nayak, B. B. (Author), Teppan, J. (Author), Red, I. (Author), Schwanzer, J. (Author), Heinemann, A. (Author) & Böhm, E. (Author)
2024Activity: Talk, presentation or poster › Poster
-
THE ROLE OF NEUTROPHIL-DERIVED MYELOPEROXIDASE (MPO) IN NON-SMALL CELL LUNG CANCER METASTASIS
Cosic Mujkanovic, N. (Author), Valadez Cosmes, P. (Author), Maitz, K. (Author), Lagler, A. (Author), Juvan, Z. N. (Author), Runtsch, M. (Author), Kienzl, M. (Author), Heinemann, A. (Author), Schicho, R. (Author), Marsche, G. (Author) & Kargl, J. (Author)
2024Activity: Talk, presentation or poster › Poster
-
A matrikine that mediates exacerbated neutrophil response
Schwanzer, J. (Author), Kwapiszewska-Marsh, G. (Author), Heinemann, A. (Author) & Jandl, K. (Author)
2023Activity: Talk, presentation or poster › Poster
-
The IL23-Th17 axis in neutrophilic airway inflammation
Nayak, B. B. (Author), Red, I. (Author), Schwanzer, J. (Author), Teppan, J. (Author), Lanz, I. (Author), Kienzl, M. (Author), Heinemann, A. (Author), Douschan, P. (Author) & Böhm, E. (Author)
2023Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Succinate aggravates pulmonary fibrosis through the succinate/SUCNR1 axis.
Rajesh, R. (Author), ATALLAH, R. (Author), Lanz, I. (Author), Platzer, W. (Author), Angiari, S. (Author), Marsh, L. (Author), Bärnthaler, T. (Author) & Heinemann, A. (Author)
2023Activity: Talk, presentation or poster › Poster